Virus Clearance Strategy Using a Three-Tier Orthogonal Technology Platform.
| Publicado en: | BioPharm International Vol. 21; no. 9; pp. 50 - 60 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108042225&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108042225 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Sep2008 vid: 21 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108042225 2011968613 108042225 ppf: 50 ppct: 10 formats: fmt: @attributes: type: P tig: atl: Virus Clearance Strategy Using a Three-Tier Orthogonal Technology Platform. aug: au: Ray, Suma Tarrach, Klaus affil: Sartorius Stedim Biotech, Goettigen, Germany sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|